Regression of endometrial implants treated with vitamin D3 in a rat model of endometriosis

European Journal of Pharmacology

Volumn 715, Issue 1-3, 2013, Pages 72-75

  Abbas, Manal A ^a   Taha, Mutasem O ^b   Disi, Ahmad M ^b   Shomaf, Maha ^b  

^a AL AHLIYYA AMMAN UNIVERSITY   (Jordan)

^b UNIVERSITY OF JORDAN   (Jordan)

Author keywords

Cholecalciferol; Endometriosis; Rat surgical model

Indexed keywords

COLECALCIFEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENDOMETRIOSIS; FEMALE; GYNECOLOGICAL AND OBSTETRIC IMPLANT; HISTOPATHOLOGY; INFLAMMATORY CELL; MICROSCOPY; NICK END LABELING; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; REMISSION; STROMA; SURGICAL APPROACH; SURGICAL TECHNIQUE;

CHOLECALCIFEROL; ENDOMETRIOSIS; RAT SURGICAL MODEL; VITAMIN D(3);

ANIMALS; CHOLECALCIFEROL; DISEASE MODELS, ANIMAL; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; RATS;

EID: 84885475314     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.06.016     Document Type: Article

References (21)

1. Agic, A., Xu, H., Altgassen, C., Noack, F., Wolfler, M.M., Diedrich, K., Friedrich, M., Taylor, R.N., Hornung, D., 2007. Relative expression of 1,25-dihydroxyvitamin D3 receptor, vitamin D1 alpha-hydroxylase, vitamin D 24-hydroxylase, and vitamin D 25-hydroxylase in endometriosis and gynecologic cancers. Reprod. Sci. 145, 486-497. (Pubitemid 351168795)
2. Bouillon, R., Verstuyf, A.M., Verlinden, L., Branisteanu, D., Mathieu, C., Van Baelen, H., 1995. Non-hypercalcemic pharmacological aspects of vitamin D analogs. Bio-chem. Pharmacol. 50, 577-583.
3. Cantorna, M.T., Munsick, C., Bemiss, C., Mahon, B.D., 2000. 1,25-Dihydroxychole-calciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J. Nutr. 130, 2648-2652.
4. Casteels, K., Bouillon, R., Waer, M., Mathieu, C., 1995. Immunomodulatory effects of 1 25-dihydroxyvitamin D3. Curr. Opin. Nephrol. Hypertens. 4, 313-318.
5. Chwalisz, K., Garg, R., Brenner, R.M., Schubert, G., Elger, W., 2002. Selective progesterone receptor modulators (SPRMs): a novel therapeutic concept in endometriosis. Ann. NY Acad. Sci. 955, 373-388. (Pubitemid 34271095)
6. Crosignani, P.G., Olive, D., Bergqvist, A., Luciano, A., 2006. Advances in the management of endometriosis: an update for clinicians. Hum. Reprod. Update 12 (2), 179-189. (Pubitemid 43231450)
7. Eltern, M., 2008. Development and Evaluation of Two Mouse Models for Endome-triosis Focused on the Involvement of the Immune System in Endometriosis Establishment (Ph.D. thesis). University of Berlin.
8. Grummer, R., 2006. Animal models in endometriosis research. Hum. Reprod. Update 12 (5), 641-649. (Pubitemid 44288713)
9. Keenan, J.A., Williams-Boyce, P.K., Massey, P.J., Chen, T.T., Caudle, M.R., Bukovsky, A., 1999. Regression of endometrial explants in a rat model of endometriosis treated with the immune modulators loxoribine and levamisole. Fertil. Steril. 72, 135-141. (Pubitemid 29300275)
10. Larsson, P., Mattsson, L., Klareskog, L., Johnsson, C., 1998. A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia. Clin. Exp. Immunol. 114, 277-283. (Pubitemid 28505730)
11. Marcondes, F.K., Bianchi, F.J., Tanno, A.P., 2002. Determination of the estrous cycle phases of rats: some helpful considerations. Braz. J. Biol. 62 (4a), 609-614.
12. 3 analogs as immunomodulatory agents. Trends. Mol. Med. 8 (4), 174-179. (Pubitemid 34297090)
13. Mathieu, C., Waer, M., Casteels, K., Laureys, J., Bouillon, R., 1995. Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060. Endocrinology 136, 866-872.
14. Nothnick, W.B., Zhang, X., 2009. Future targets in endometriosis treatment: targeting the endometriotic implant. Mini Rev. Med. Chem. 9, 324-328.
15. O'Brien, M.A., Jackson, M.W., 2012. Vitamin D and the immune system: beyond rickets. Vet. J. 194, 27-33.
16. Panay, N., 2008. Advances in the medical management of endometriosis. Brit. J. Obstet. Gynaec. 115, 814-817. (Pubitemid 351693017)
17. Rice, V.M., 2002. Conventional medical therapies for endometriosis. Ann. NY. Acad. Sci. 955, 343-352. (Pubitemid 34271092)
18. Seko, M., Takeuchi, H., Kinoshita, K., Tokita, A., 2004. Association of bone mineral density with vitamin D and estrogen receptor gene polymorphisms during GnRH agonist treatment. J. Obstet. Gynaecol. Res. 30 (2), 130-135. (Pubitemid 38508628)
19. Van Etten, E., Decallonne, B., Mathieu, C., 2002. 1,25- dihydroxycholecalciferol: endocrinology meets the immune system. Proc. Nutr. Soc. 61, 375-380. (Pubitemid 34982928)
20. Van Etten, E., Decallonne, B., Verlinden, L., Verstuyf, A., Bouillon, R., Mathieu, C., 2003. Analogs of 1,25-dihydroxyvitamin D3 as pluripotent immunomodulators. J. Cell. Biochem. 88, 223-226.
21. Yao, Z., Shen, X., Capodanno, I., Donnelly, M., Fenyk-Melody, J., Hausamann, J., Nunes, C., Strauss, J., Vakerich, K., 2005. Validation of rat endometriosis model by using raloxifene as a positive control for the evaluation of novel SERM compounds. J. Invest. Surg. 18, 177-183. (Pubitemid 41200609)